The DOI matches its Crossref record.
Epidemiological Analysis of Alcohol and Drug Use as Risk Factors for Psychotic Experiences
Abstract
Clinical and laboratory studies link alcohol and other drug use to the occurrence of psychotic experiences, but epidemiologic evidence has been lacking. In this study, the quantitative relationships between alcohol or other drug use and psychotic experiences were examined by analysis of prospective data from 4994 adult household residents sampled in a multisite survey of mental disorders in the population, the NIMH Epidemiologic Catchment Area Program. After control for sociodemographic factors and preexisting psychiatric conditions, the risk for onset of self-reported delusions or hallucinations was observed to be greater for daily users of marijuana or cocaine and for users of anxiolytics or sympathomimetics compared with nonusers. After control for daily cocaine use and alcohol disorder, the risk of onset of psychotic experiences for daily users of marijuana was double that for nonusers. Alcohol disorder in men was associated with eightfold risk and in women with threefold risk. Baseline depressive episodes, manic episodes, agoraphobia, and obsessive-compulsive disorder also were associated with increased risk of onset of psychotic experiences. — J Nerv Ment Dis 178:473-480, 1990
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“In the ECA study (20) daily cannabis use was associated with increased risk of psychotic experiences, although there was little evidence that ever use of cannabis was associated with these experiences.”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
In the citing paper
“| ECA (20) | 2295 | Daily use of | Psychotic | 2.0 | Large sample | No |”
From Association Between Cannabis and Psychosis: Epidemiologic Evidence (2016) · cites this paper as [20]
Citations
Cited by
Sorted by citations
van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003814 · Cited by 2,343
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Linscott, R. J., & van Os, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001626 · Cited by 1,181
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 924
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Metadata
- Authors
- TIEN, A. Y., & ANTHONY, J. C.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 1990-08
- Volume
- 178
- Issue
- 8
- Pages
- 473-480
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W2019502220
- Cited by
- 175
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 9 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Nervous and Mental Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh041908-04, 5r01da003992-04)
- National Institute of Mental Health (MH41908, MH-14592, T32MH014592)
- National Institute on Drug Abuse (DA03992)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- alcohol consumption, drug use, psychotic experiences, delusions, hallucinations, cannabis, cocaine, anxiolytics, sympathomimetic drugs, alcohol-related disorders, substance use risk factors, depressive episodes, manic episodes, agoraphobia, obsessive-compulsive disorder
- MeSH terms
- Alcoholism, Mental Disorders, Marijuana Abuse, Cocaine, Delusions, Epidemiologic Methods, Hallucinations, Humans, Prospective Studies, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
